Clinical Efficacy of LivPro® Herbal Medicine among Hepatitis C Patients Pakistan: Longitudinal Interventional Study

TLDR

The study investigates the hepatoprotective effects of LivPro® in hepatitis C patients. An interventional study of 89 patients over 3 months measured liver function, ELISA, and viral load monthly, with statistical significance assessed at 95% CI. The interventional study was conducted in Pakistan.

Abstract

The current study aims to investigate the hepatoprotective effects of LivPro® among hepatitis C patients. An interventional study was performed among n=89 hepatitis C patients. The duration of the study was 3 months and the assessment for liver function, ELISA, and Viral load was performed monthly for the patients recruited in this study. Mean difference was measured and at a Confidence Interval (CI 95%) p-value less than 0.05 was considered statistically significant. This interventional stu